Home › Funds › Kiltearn Partners LLP › HCA

Kiltearn Partners LLP position in HCA

HCA HEALTHCARE INC · Health Care

Kiltearn Partners LLP reported holding 42,019 shares of HCA (HCA HEALTHCARE INC) in its Q3 2026 13F filing — a position valued at US$17.9M, representing 4.32% of its reported portfolio and ranking #8 among its reported holdings. Kiltearn Partners LLP has disclosed HCA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)42.02K sh
Reported value held$17.93M
Portfolio Weight4.32%
First reportedQ3 2023
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Kiltearn Partners LLP's HCA position evolved

Kiltearn Partners LLP first disclosed a stake in HCA in Q3 2023 at 147,700 shares (US$36.3M). The position peaked in Q4 2023 at 172,300 shares, worth US$46.6M. Across 13 filings, Kiltearn Partners LLP increased the stake 4 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 42,019 shares valued at US$17.9M — an increase of 4,705 shares quarter over quarter.. Notable position changes include a 37% trim in Q2 2024 (shares rose 26% over the following quarter), a 38% trim in Q3 2024 (shares fell 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 147.70K $36.33M New
Q4 2023 172.30K $46.64M Add
Q1 2024 140.00K $46.22M Reduce
Q2 2024 88.10K $28.30M Reduce
Q3 2024 54.80K $22.27M Reduce
Q4 2024 49.70K $14.92M Reduce
Q1 2025 42.70K $14.75M Reduce
Q2 2025 39.50K $15.13M Reduce
Q3 2025 42.70K $18.20M Add
Q4 2025 35.80K $16.71M Reduce
Q1 2026 30.00K $14.20M Reduce
Q2 2026 37.31K $14.55M Add
Q3 2026 42.02K $17.93M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HCA and 13F data

HCA (HCA HEALTHCARE INC) is a Health Care company. 24 other funds we track also report a position in HCA — the largest reported positions include Sanders Capital, LLC (US$3.75B), First Eagle Investment Management (US$1.39B), Arrowstreet Capital (US$851.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HCA

All HCA fund holders →

FAQ

How long has Kiltearn Partners LLP held HCA?

Kiltearn Partners LLP has disclosed HCA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Kiltearn Partners LLP's current position in HCA?

As of Q3 2026, Kiltearn Partners LLP holds 42.02K shares of HCA (HCA HEALTHCARE INC), valued at $17.93M, representing 4.32% of its reported portfolio and ranking #8.

Has Kiltearn Partners LLP been buying or selling HCA?

In the latest 13F filing (Q3 2026), Kiltearn Partners LLP increased its position in HCA. The position peaked in Q4 2023 at 172.30K shares.

Which other funds hold HCA?

Other major institutional holders of HCA include Sanders Capital, LLC, First Eagle Investment Management, Arrowstreet Capital, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.